Have You Ever Injected Drugs? What You Need to Know About Hepatitis C
Changing epidemiology, implications, and recommendations for hepatitis C in women of childbearing age and during pregnancy.
Kushner T, Reau N. J Hepatol. 2021;74(3):734-741.
Lopata SM, et al. Pediatrics. 2020;145(3):e20192482.
“Everybody living with a chronic disease is entitled to be cured”: challenges and opportunities in scaling up access to direct-acting antiviral hepatitis C virus treatment among people who inject drugs.
Goodyear T, et al. Int J Drug Policy. 2020;81:102766.
Grebely J, Dore GJ. Clin Liver Dis. 2017;9(4):77-80.
Barriers and facilitators to engaging in hepatitis C management and DAA therapy among general practitioners and drug and alcohol specialists—the practitioner experience.
Marshall AD, et al. Drug Alcohol Depend. 2020;206:107705.
Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: a meta-analysis.
Hajarizadeh B, et al. J Hepatol. 2020;72(4):643-657.
Rosenthal ES, et al. Clin Infect Dis. 2020;71(7):1715-1722.
Clients’ perceptions of barriers and facilitators to implementing hepatitis C virus care in homeless shelters.
Masson CL, et al. BMC Infect Dis. 2020;20(1):386.
HCV in People Who Inject Drugs
A Call to Action for Frontline Providers
|Faculty:||Beth A. Dunlap, MD; Stacey B. Trooskin, MD, PhD, MPH|
Addressing the Real-World Challenge of HCV Cure in People Who Inject Drugs
Opportunities for Current and New HCV Treaters
|Faculty:||Andrew I. Aronsohn, MD; Stacey B. Trooskin, MD, PhD, MPH|